Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 268

Results For "RI"

11152 News Found

Novartis Tafinlar and Mekinist demonstrates unprecedented efficacy in pediatric patients
News | June 08, 2022

Novartis Tafinlar and Mekinist demonstrates unprecedented efficacy in pediatric patients

If approved, Tafinlar + Mekinist may offer a potential new standard-of-care for pediatric patients with this brain cancer


India is dedicated to ensure health Security for every citizen: Mandaviya
Policy | June 08, 2022

India is dedicated to ensure health Security for every citizen: Mandaviya

States have an important role in ensuring food safety and healthy food practices.


NHA organizes orientation workshop on Ayushman Bharat Digital Mission in Mumbai
Policy | June 08, 2022

NHA organizes orientation workshop on Ayushman Bharat Digital Mission in Mumbai

The second phase of the orientation workshop is being organized to provide in-depth knowledge to the state officials on core building blocks of ABDM


Novartis Scemblix shows better result for chronic myeloid leukemia trial
Clinical Trials | June 08, 2022

Novartis Scemblix shows better result for chronic myeloid leukemia trial

Scemblix (asciminib) continues to show superior efficacy with more-than-two-fold improvement in major molecular response rate vs. Bosulif (bosutinib) at 96 weeks


Merck and Ridgeback announce new data for investigational molnupiravir
News | June 08, 2022

Merck and Ridgeback announce new data for investigational molnupiravir

Based on a post hoc analysis, fewer required respiratory interventions


Gufic Biosciences to grab a major share of Rs. 3,000 crore lyophilized antibacterial market
News | June 07, 2022

Gufic Biosciences to grab a major share of Rs. 3,000 crore lyophilized antibacterial market

The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price


MEI Pharma and Kyowa Kirin report new clinical data on Zandelisib
News | June 07, 2022

MEI Pharma and Kyowa Kirin report new clinical data on Zandelisib

he Phase 2 TIDAL data generated to date continue to highlight zandelisib's therapeutic profile and the potential to benefit patients


APhA appoints Ilisa Bernstein Interim CEO
People | June 06, 2022

APhA appoints Ilisa Bernstein Interim CEO

Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA


FDA publishes ANP’s polymeric drug excipient DMF
Drug Approval | June 06, 2022

FDA publishes ANP’s polymeric drug excipient DMF

The DMF#36513 demonstrates ANP’s success in the development of its “Plug and Play” drug delivery platform.


AstraZeneca’s Pascal Soriot awarded British knighthood for services to UK
People | June 04, 2022

AstraZeneca’s Pascal Soriot awarded British knighthood for services to UK

AstraZeneca also played a critical role in the global response to COVID-19.